Treatment Outcomes in Unfit Patients with Newly Acute Myeloid Leukemia According to IDH1 Mutational Status: Real World Evidence from the Pethema Epidemiologic RegistryDavid Martínez‐Cuadrón, Pau Montesinos, Juan Miguel Bergua Burgués et al.|Blood|2023Cited by 2
Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?Edwin Uriel Suárez, Blanca Boluda, Esperanza Lavilla et al.|Annals of Hematology|2024Cited by 1